3Balkis Budin S, Othman F, Louis SR, et al. Effect of alphalipoic acid on oxidative stress and vascular wall of diabeticrats. Rom J Morphol Embryol, 2009, 50 (1) :232-301.
4Brownlee M. The pathophysiology of diabetic complications:a unifying mechanism. Diabetes, 2005, 54:1 615-1 625.
5McCarter RJ , Hempe JM , Chalew SA. Mean blood glucose and biological variation have greater influence on HbAlc levels than glucose instability. Diabetes Car, 2006, 29(2):352-355.
6Monnier L, Mas E, Ginet C, et al. Activat ion of ox idative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA, 2006, 295:1 681-1 687.
7Nishikawa T, Sasahara T, Kiritoshi S, et al. Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care, 2003,26 (5):1 507-1 512.
8Quagliaro L, Piconi L, Assaloni R, et al. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD (P)H-oxidase activation. Diabetes,2003,52(11) :2 795-2 804.
9Zhao Linshuang, Liao Yuhus, Xiang Guangda, et al. Preliminary clinical trial on serum 61 and M2 autoantibody in type II diabetes patients with accompanied refractory hypertension. Chinese Journal of Cardiology, 2006, 34(5):407-410.
10Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. New Engl J Med,2008,3(58):2 545-2 559.
